Research Site

Saint-Grégoire 35768

1 studies enrolling now · 5 studies all time

What they study most

Colorectal Cancer, Non-Small Cell Lung Cancer, Recurrent or Metastatic PD-L1-positive Squamous Cell Carcinoma of the Head and Neck, Recurrent or Metastatic PD-L1-positive or -Negative Squamous Cell Carcinoma of the Head and Neck SCCHN, Recurrent/Metastatic Squamous Cell Carcinoma of Head & Neck

Studies at this site

• A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC — Recruiting now
• Study of MEDI4736 Monotherapy and in Combination With Tremelimumab Versus Standard of Care Therapy in Patients With Head and Neck Cancer — Completed
• Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck — Completed
• Phase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck — Completed
• First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX — Completed